Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Question-Based Review Not Raising Questions For Generic Sponsors, FDA

Executive Summary

Initial experiences with question-based reviews of the chemistry, manufacturing and controls section of ANDAs suggest the quality initiative will not adversely affect the generics review process for sponsors
Advertisement

Related Content

ANDA question-based-review adherence
ANDA question-based-review adherence
ANDA Review Improvements Continue As FDA Eyes Generic User Fee Resources
ANDA Review Improvements Continue As FDA Eyes Generic User Fee Resources
“First Generics” Will Get Expedited ANDA Reviews Under New FDA Policy
FDA Creates CMC Pilots To Put Quality Assessment Principles Into Practice
FDA Creates CMC Pilots To Put Quality Assessment Principles Into Practice
Advertisement
UsernamePublicRestriction

Register

PS047759

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel